2012/06/18 Dr. Luo will attend BIO 2012 in Boston, USA, and he will present about how to expedite the fibrotic drug development in China.

2012/04 The China Pharmaceutical & Biotechnology Review, a monthly publication covering all aspects of the industry (2012 volume 58), published a panel discussion with Dr. Ying Luo and other Experts from biotechs and research institutes in China.

2012/03/11 Dr. Luo was invited to attend Drug Discovery World Asia 2012 in Singapore, and he reviewed the development of orphan drug F647 in China and received video interview.

2012/03/14 The Chinese Pharmacological Bulletin (2012 Jan: 28(1): 136-9) pulished an article authored by National Institute for Food and Drug Control. The article included the results of F573's therapeutic effect on ConA-induced acute liver injury in mice. Dr. Luo is the co-author of the article.

 
© 2007~2018 shanghaigenomics.com. All rights reserved. Shanghai ICP 08017875